MIR4660

Across TCGA pan-cancer cohorts, MIR4660 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR4660 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR4660 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4660 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

ACC, LUAD, and BLCA are the cancer types where MIR4660 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.010	0.458	<.001	81	view →
LUAD	DFS	Tertile	IV	0.109	0.714	.001	60	view →
BLCA	DFS	Tertile	III,IV	0.587	0.266	.005	51	view →
KIRP	DFS	Tertile	IV	0.088	0.511	.002	51	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
LGG	OS	Tertile	All	0.215	0.457	.004	33	view →
LIHC	DFS	Tertile	All	0.332	0.568	.004	24	view →
KIRC	OS	Tertile	All	0.478	0.687	.008	18	view →
THCA	OS	Tertile	IV	0.720	1.000	.004	18	view →
HNSC	OS	Tertile	III,IV	0.718	0.341	.020	12	view →
MESO	OS	Tertile	IV	0.313	0.661	.016	9	view →
ESCA	OS	Quartile	All	0.386	0.606	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR4660–ACC (DFS)

Open the ACC breakdown →